Document is current
Any future updates will be listed below
-
Authors
Kevane-Campbell, Max
Idris, Raja
Würstle, Silvia
Lieberknecht, Simone
Vehreschild, Maria J. G. T.
Wichelhaus, Thomas A.
Wetzstein, Nils
-
Funding
Funding for this research was provided by:
Johann Wolfgang Goethe-Universität, Frankfurt am Main
- License Information
-
More Information
Article History
Received: 9 February 2026
Accepted: 1 May 2026
First Online: 1 June 2026
Declarations
:
: Max Kevane-Campbell, Simone Lieberknecht, Silvia Würstle and Nils Wetzstein have nothing to disclose. Raja Idris received speaker fees from Tillotts Pharma and Gilead Sciences outside the submitted work. Thomas A. Wichelhaus reports research grants from BMBF, JPIAMR, Deutsche Krebshilfe, MSD as well as speaker fees and consulting honoraria from Landesärztekammer Hessen, Insmed, Osartis, all outside the submitted work. Maria J.G.T. Vehreschild reports grants from MSD, Heel, Roche, Tillotts; consulting fees from GILEAD, Tillotts, Pfizer, Bioaster, GSK, Ecraid, Eumedica, Bactolife, and payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Akademie für Infektionsmedizin, Astra Zeneca, bioMerieux, Biotest, DGI, European Society of Neurogastroenterology, Falk Foundation, FomF GmbH, GILEAD, GSK, Helios Kliniken, Hessisches Landessozialgericht, Infektio Forum, Janssen Cilag GmbH, Klinikum Kasseln, Landesärztekammer Hessen, LMU Kliniken, MSD, Pfizer, Streamed up, St. Vincent Hospital, Tillotts.
: Not applicable.
: Not applicable.
